Prot#CV013020:A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Cross-over Phase 2 Study of Continuous 5-Hour Intravenous Infusions of BMS-986231 in Patients with Heart Failure and Impaired Systolic Function

Project: Research project

Project Details

StatusFinished
Effective start/end date7/13/18 → 7/13/21

Funding

  • PPD Investigator Services, LLC (Prot#CV013020 // Prot#CV013020)
  • Bristol-Myers Squibb Company (Prot#CV013020 // Prot#CV013020)